New research finds no link between aluminum in vaccines and autism, asthma, or other health conditions, strengthening the case for vaccine safety.
A large register-based study conducted in Denmark has reinforced the safety of childhood vaccines, finding no association between aluminum-containing vaccines and an increased risk of autism, asthma, autoimmune diseases, or 47 other health conditions. The findings, based on data from over one million children, provide further evidence that aluminum adjuvants used in vaccines do not pose a risk to child health.1
Published in the Annals of Internal Medicine, the study analyzed health outcomes in children born between 1997 and 2018. Researchers investigated 50 potential health conditions, including neurodevelopmental disorders and allergies, and found no significant links between these conditions and the small amounts of aluminum used in vaccines.2
The study, conducted by Statens Serum Institut (SSI), aimed to assess the potential impact of aluminum exposure from childhood vaccinations on the development of chronic conditions, including autoimmune, atopic/allergic, and neurodevelopmental disorders. It followed a cohort of 1,224,176 children born between 1997 and 2018, using Denmark's comprehensive national health registers. The children were tracked until the age of 2 years to assess their exposure to aluminum from vaccines during early childhood.2
The results showed that cumulative aluminum exposure from early childhood vaccinations was not associated with an increased risk for any of the 50 chronic disorders evaluated, including autoimmune diseases (such as dermatologic, endocrinologic, hematologic, gastrointestinal, and rheumatic conditions), atopic or allergic conditions (such as asthma, atopic dermatitis, rhinoconjunctivitis, and allergy), and neurodevelopmental disorders (including autism spectrum disorder and attention deficit–hyperactivity disorder, ADHD).2
For combined outcome groups, the study found the following adjusted hazard ratios (HR) per 1-mg increase in aluminum exposure:2
The upper bounds of the 95% confidence intervals (CIs) for most outcomes were inconsistent with relative increases greater than 10% or 30%, suggesting that the risk of these conditions was unlikely to be increased due to aluminum exposure.2
In terms of individual disorders, the study found that the upper bounds of the 95% CIs ruled out relative increases greater than 10% for 19 outcomes, greater than 30% for 7 outcomes, and for the 4 remaining rarer outcomes, increases ranging from 31% to 79%. These rarer outcomes had much lower incidence rates, ranging from 7.6 to 14.9 per 1 million person-years.2
The study did have some limitations. First, it relied on registry data, meaning it lacked the randomization of exposure that would be found in controlled clinical trials. As a result, there could be residual confounding from unmeasured variables. Additionally, while the study used data from the Danish National Health Service Register, which is highly valid, there may still have been some misclassification of exposure. Lastly, because the study primarily focused on disorders diagnosed early in childhood, some rare disorders that develop later in life could not be thoroughly analyzed.2
Despite these limitations, the study provides strong evidence that early childhood exposure to aluminum-adsorbed vaccines does not increase the risk for autoimmune, atopic, or neurodevelopmental disorders. Although the study could not completely exclude small relative effects for some rare outcomes, the overall findings suggest that aluminum adjuvants in vaccines do not pose a significant health risk to children.2
According to Anders Hviid, head of department at SSI and principal investigator of the study, "Our results are reassuring. By analyzing data from more than one million Danish children, we found absolutely no indication that the very small amount of aluminum used in the childhood vaccination program increases the risk of 50 different health outcomes during childhood," he said in the press release.1
Aluminum has been used as an adjuvant in vaccines since the 1930s to enhance immune response. Despite its longstanding use and established safety profile, concerns about aluminum's role in vaccines have persisted in public discourse.1
These findings come at a time when vaccine safety remains a contentious issue globally, especially amid widespread misinformation. Hviid emphasized the importance of relying on robust scientific evidence to guide vaccine policy, particularly in the face of politicized health science. “In an era marked by widespread misinformation about vaccines, it is crucial to rely on solid scientific evidence. Large, population-based register studies like this one are a bulwark against the politicization of health science, which undermines public trust in vaccines. It is absolutely essential to distinguish real science from politically motivated campaigns—otherwise, it is the children who will end up paying the price,” Hviid stated.1
In the US, vaccine skepticism remains a significant issue, with 30% of adults expressing doubts about vaccines. This skepticism is particularly notable amid an ongoing measles outbreak and persistent concerns about vaccine safety, including the widely debunked myth linking vaccines to autism.1
A large-scale Danish study found no increased risk of autism, asthma, or autoimmune diseases in children receiving aluminum-containing vaccines.
The research, based on data from over 1 million children, supports the safety of aluminum adjuvants, which have been used in vaccines for nearly a century.
Experts stress the importance of relying on large-scale, evidence-based studies to counter misinformation and maintain public trust in vaccines.
A recent
The survey also uncovered stark political divides in vaccine attitudes, with 50% of Republicans expressing skepticism, compared to just 16% of Democrats. Despite these divides, 41% of respondents expressed concern that vaccine skepticism could hinder access to immunizations, potentially undermining efforts to protect public health, particularly in low-income and rural areas.3
As vaccine skepticism continues to challenge immunization efforts, experts emphasize the importance of science-driven policies and transparent decision-making to maintain public trust in vaccines and safeguard global health.
